UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010804 |
|---|---|
| Receipt number | R000012127 |
| Scientific Title | Phase II study of Pemetrexed and Cisplatin plus Bevacizumab with Maintenance Pemetrexed as First-Line Therapy for Nonsquamous Non-small-cell Lung Cancer (ALCT001) |
| Date of disclosure of the study information | 2013/05/25 |
| Last modified on | 2015/06/07 01:13:05 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/05/25 23:52:01 | ||
| 2 | Update | 2014/03/02 21:53:18 | Public title Public title Acronym Acronym |
|
| 3 | Update | 2014/04/23 04:34:25 | Narrative objectives1 |
|
| 4 | Update | 2014/04/23 04:36:39 | Narrative objectives1 |
|
| 5 | Update | 2015/06/07 01:06:56 | Email Email1 |
|
| 6 | Update | 2015/06/07 01:08:24 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 7 | Update | 2015/06/07 01:13:05 | Recruitment status |
